The Interventional Oncology Center

Filter Your Results

 

News

 

Managing Aortic Pseudoaneurysm Caused by Metastatic Choriocarcinoma

Bibombe P. Mwipatayi, MMED (SURG), FCS (SA), CERT VASC SURG (SA), FRACS; Shannon Thomas, BMEDSC (HONS), MBBS (HONS); Sarah Norton, MBBS; and Vikram Vijayan, MBCHB, MRCS, FRCS

April 2010—A case in which a custom-made graft is used to successfully treat an unusual aortic defect.

Drug-Eluting Beads Versus Conventional TACE

Riccardo Lencioni, MD

April 2010—Where do we stand in the transcatheter treatment of patients with hepatocellular carcinoma?

CO2 Angiography in Interventional Oncology

James Caridi, MD, FSIR; Jeffery D. Vogel, MD; Darren Postoak, MD; Scott Peterson, MD; Brian S. Geller, MD; Irvin Hawkins, MD; and Sean Wiley, RPA

April 2010—CO2 angiography not only helps prevent undesired complications, but it can also assist in the performance of interventional oncologic procedures.

Do Particle Size and Type Matter?

Robert L. Worthington-Kirsch, MD

June 2008—Lessons learned from experience with uterine artery embolization.

Yttrium-90 Radioembolization

David M. Liu, MD, FRCP(C); David N. Cade, MD; Jesse Knight, MD; Rodney Raabe, MD; Stephen Kee, MD; Andrew Kennedy, MD, FACRO; and Riad Salem, MD, FSIR, MBA

June 2008—Recent advances in hepatic embolotherapy.

 

advertisement

2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.